Skip to main content
Frontiers in Endocrinology logoLink to Frontiers in Endocrinology
. 2024 Nov 15;15:1517690. doi: 10.3389/fendo.2024.1517690

Corrigendum: Surgical outcome and malignant risk factors in patients with thyroid nodule classified as Bethesda category III

Jianhao Huang 1,2,, Hongyan Shi 1,3,, Muye Song 1,4,, Jinan Liang 1,3, Zhiyuan Zhang 1,3, Xiaohang Chen 1,2, Yongchen Liu 1, Sanming Wang 1, Zeyu Wu 1,*
PMCID: PMC11604988  PMID: 39619327

In the published article, there was an error in the Funding statement. The Funding statement for the Guangdong Basic and Applied Basic Research Foundation was displayed as “Natural Science Foundation of Guangdong Province (No. 2020A1515010127)”. The correct statement is “Guangdong Basic and Applied Basic Research Foundation (No. 2020A1515010126)”. The correct Funding statement appears below.

“This work was supported by Guangdong Basic and Applied Basic Research Foundation (No. 2020A1515010126), Scientific Research Staring Foundation for the Returned Overseas from Guangdong Provincial People’s Hospital (No. 2017x02) and Guangdong Provincial People’s Hospital Scientific Foundation for Distinguished Young Scholars of Guangdong Province (No. KJ012019441).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Endocrinology are provided here courtesy of Frontiers Media SA

RESOURCES